Humanized bone marrow mouse model as a preclinical tool to assess therapy-mediated hematotoxicity. - Wikidata - wikimedia - TriplyDB

Humanized bone marrow mouse model as a preclinical tool to assess therapy-mediated hematotoxicity.

Humanized bone marrow mouse model as a preclinical tool to assess therapy-mediated hematotoxicity.

http://www.wikidata.org/entity/Q34810016

about

Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer Leishmania major infection in humanized mice induces systemic infection and provokes a nonprotective human immune response Human adipose-derived stromal/stem cells protect against STZ-induced hyperglycemia: analysis of hASC-derived paracrine effectors.Assessment of benzene-induced hematotoxicity using a human-like hematopoietic lineage in NOD/Shi-scid/IL-2Rγnull mice Design, synthesis, and evaluation of curcumin-derived arylheptanoids for glioblastoma and neuroblastoma cytotoxicity Abiraterone acetate in patients with metastatic castration-resistant prostate cancer: long term outcome of the Temporary Authorization for Use programme in France.Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model.Streptozotocin is equally diabetogenic whether administered to fed or fasted mice Clonal Dominance With Retroviral Vector Insertions Near the ANGPT1 and ANGPT2 Genes in a Human Xenotransplant Mouse Model.Temozolomide-mediated DNA methylation in human myeloid precursor cells: differential involvement of intrinsic and extrinsic apoptotic pathways.The Role of MDM2 in Promoting Genome Stability versus Instability.Combination therapy in a xenograft model of glioblastoma: enhancement of the antitumor activity of temozolomide by an MDM2 antagonist.

P2860

Q26780387-EBA4CAF0-E416-42E3-9BE4-99B29861C0C8 Q28481520-BAD7E133-E41A-4721-999A-50225D06CE55 Q33779347-4553D1C9-F5B3-4D47-AD57-31C1C9C9F8E2 Q34506515-C7F8014D-6568-4845-8393-663BBAC0C14E Q34555833-69244D67-E466-4684-BAB2-6438BE28A5B7 Q35358010-99ADBE6D-A3EC-473D-A93F-898B939DB3CF Q36359692-F3568B78-E5AB-4614-9C63-16E1DA009904 Q37170577-B9E8556A-CEBD-4FD1-BA14-F363FC7A55F3 Q42184255-134DFC2D-CDFD-4A7F-8219-9354F66D12D4 Q43092195-A53442E6-F52F-4337-9D8A-C6C77821F347 Q47096280-9B851275-4432-4B84-BC39-BF335C84CE56 Q47798259-7274F937-2825-47EB-8A54-C363086020E6

P2860

Humanized bone marrow mouse model as a preclinical tool to assess therapy-mediated hematotoxicity.

http://www.wikidata.org/entity/Q34810016

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Humanized bone marrow mouse mo ...... erapy-mediated hematotoxicity.

@ast

Humanized bone marrow mouse mo ...... erapy-mediated hematotoxicity.

@en

Humanized bone marrow mouse mo ...... erapy-mediated hematotoxicity.

@nl

type

label

Humanized bone marrow mouse mo ...... erapy-mediated hematotoxicity.

@ast

Humanized bone marrow mouse mo ...... erapy-mediated hematotoxicity.

@en

Humanized bone marrow mouse mo ...... erapy-mediated hematotoxicity.

@nl

prefLabel

Humanized bone marrow mouse mo ...... erapy-mediated hematotoxicity.

@ast

Humanized bone marrow mouse mo ...... erapy-mediated hematotoxicity.

@en

Humanized bone marrow mouse mo ...... erapy-mediated hematotoxicity.

@nl

P1433

Q34810016-18BD3893-7FAA-4326-A60B-BD776A49B69C

P1476

Q34810016-1E963FC9-70EB-4FF4-950F-8D07063E5EFA

P2093

Q34810016-022D916C-5BCD-48C6-9C3A-CA900B7D7ACE

Q34810016-121E6C13-026A-4D51-8122-926A475976C6

Q34810016-1C66AA13-2F44-40E5-988F-204836FDAF66

Q34810016-48093633-D889-4A29-9B79-E7483AED440E

Q34810016-588A0E09-4256-4DC0-B763-2619B17090A6

Q34810016-6B951A03-73CF-4D05-97D3-35A56D53C49E

Q34810016-7E01CFBE-4AE6-4A5E-98DD-B40CF39E081D

Q34810016-9261F916-3F8D-4D1B-9723-B6D61EB5C14F

Q34810016-B33FF3FE-89BB-490F-9027-5B095D9154BA

Q34810016-B98BE5DB-FE67-45B1-A6E4-1D8F78E87151

P2860

Q34810016-09E4412E-64B7-4FD0-BEC6-FECDDED4D0DF

Q34810016-131CF000-D72A-499C-BE62-2B6921164797

Q34810016-134503A4-4D27-4E50-8F5A-24EECD1C282D

Q34810016-1704C4EE-15EC-48FA-A1E4-FC9E8130944A

Q34810016-184B35CD-7BB1-4596-9AF6-4D5B53B9254E

Q34810016-1F6D0344-77D3-4DCE-836C-FEDB89B73EF0

Q34810016-1FF07D96-ABB6-471F-94F8-0601FA078326

Q34810016-27888767-9564-4359-AF5A-522265146A09

Q34810016-31650DC3-1A1A-4980-B1C9-AE8DE5D72A62

Q34810016-332A02F8-CCF9-41EE-9A4A-8ED9BE8943C6

P304

Q34810016-F0296514-AE38-4307-A520-991ECFD62BDC

P31

Q34810016-B6FB393E-068E-4261-B486-BE183450A406

P356

Q34810016-E5D147E4-F510-49B1-867F-3796B1421085

P407

Q34810016-CE9C9DA8-D4B5-40A7-9D34-1ABED482A49C

P433

Q34810016-1CC63F07-DAB2-4027-918E-00683DA351D2

P478

Q34810016-B7B11C09-1272-4619-8C53-F4B6AA5612B1

P50

Q34810016-3AA3E087-8086-4AAF-AB5B-304BA201576F

P577

Q34810016-225E25E9-4776-4408-862F-C3E8EF2C7B3B

P698

Q34810016-267F1BE5-0B28-46D7-9DCE-26FE57D9D6DE

P921

Q34810016-8057A81E-8B00-4F87-8A70-6CC6815DE5C8

P932

Q34810016-15CE306F-E6DA-40F7-B8AB-A542B46083EE

P356

1078-0432.CCR-10-1959

P1433

Clinical Cancer Research

P1476

Humanized bone marrow mouse mo ...... erapy-mediated hematotoxicity.

@en

P2093

Aaron Ernstberger

http://www.w3.org/2001/XMLSchema#string

Anthony L Sinn

http://www.w3.org/2001/XMLSchema#string

Arthur R Baluyut

http://www.w3.org/2001/XMLSchema#string

Barbara Bailey

http://www.w3.org/2001/XMLSchema#string

Beth E Juliar

http://www.w3.org/2001/XMLSchema#string

David R Jones

http://www.w3.org/2001/XMLSchema#string

Haiyan Wang

http://www.w3.org/2001/XMLSchema#string

Lindsey D Mayo

http://www.w3.org/2001/XMLSchema#string

Rebecca J Chan

http://www.w3.org/2001/XMLSchema#string

Shanbao Cai

http://www.w3.org/2001/XMLSchema#string

P2860

Phase II trial of temozolomide plus o6-benzylguanine in adults with recurrent, temozolomide-resistant malignant glioma

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice

Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma

Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment

Phase I trial of carmustine plus O6-benzylguanine for patients with recurrent or progressive malignant glioma.

Phase I trial of single-dose temozolomide and continuous administration of o6-benzylguanine in children with brain tumors: a pediatric brain tumor consortium report.

Predicting hematological toxicity (myelosuppression) of cytotoxic drug therapy from in vitro tests.

Depletion of mammalian O6-alkylguanine-DNA alkyltransferase activity by O6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents.

Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic.

P304

2195-2206

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-10-1959

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

Karen E. Pollok

P577

2011-04-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21487065

http://www.w3.org/2001/XMLSchema#string

P921

P932

3078977

http://www.w3.org/2001/XMLSchema#string